Long_shortguy
2 years ago
MORE GOOD NEWS: Tel Aviv, Israel, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, announced today that its affiliate Gix Internet, (“Gix”) in which Medigus holds 42.69% of its outstanding shares (49.11% on a fully diluted basis) (TASE: GIX), a global marketing technology (MarTech) solutions company for online performance-based-marketing, reported its financial results for the first six month ended June 30, 2022.
Gix’s reported revenues for the first half of 2022 amounted to approx. $43.4 million (NIS 141.8 million), an increase of 166% compared to the revenues of approx. $16.3 million (NIS 53.3 million) in the same period of 2021.
Gix's operating profit for the six months ended June 30, 2022 amounted to approx. $0.6 million (NIS 2.2 million), compared to an operating loss of approx. $0.37 million (NIS 1.2 million) in the same period of 2021.
"Increasing our ownership in Gix, was one of our main focuses over the past year, mainly due to our trust in Gix's ability to grow. We are excited about Gix's financial results and believe in its future and its continued growth", commented Liron Carmel, Medigus Chief Executive Officer.
Medigus is expected to consolidate Gix' financial results (commencing February 28, 2022) in its financial reporting for the first half of 2022.
Shift-4
2 years ago
Jeffs' Brands Ltd. Announces Pricing of $15.5 Million Initial Public Offering
Tel Aviv, Israel, Aug 26, 2022 (GLOBE NEWSWIRE via COMTEX) -- Tel Aviv, Israel, Aug. 26, 2022 (GLOBE NEWSWIRE) -- Jeffs' Brands Ltd., a data-driven e-commerce company operating on the Amazon Marketplace, announced today the pricing of its initial public offering of 3,717,473 units. Each unit is being offered at a public offering price per unit of $4.16 and consists of one ordinary share and one warrant to purchase one ordinary share, with an initial exercise price of $4.04 per share. The gross proceeds of the offering are expected to be approximately $15.5 million before deducting underwriting discounts and other estimated offering expenses. The offering is expected to close on Tuesday, August 30, 2022, subject to satisfaction of customary closing conditions.
In addition, the Company has granted Aegis Capital Corp. ("Aegis") a 45-day option to purchase up to such number of additional ordinary shares and/or warrants, equal to 15% of the number of units sold in the offering solely to cover over-allotments, if any. The purchase price to be paid per additional ordinary share will be equal to the public offering price of one unit (less $0.01 allocated to each warrant), less the underwriting discount. The purchase price to be paid per additional warrant will be $0.01. If Aegis exercises the option to purchase only such warrants, additional proceeds will be nominal. If Aegis exercises the option in full for ordinary shares, the total gross proceeds of the offering including overallotment are expected to be approximately $17.8 million before deducting underwriting discounts and offering expenses.
The ordinary shares and warrants have been approved for listing on the Nasdaq Capital Market and are expected to begin trading on the Nasdaq Capital Market under the symbols "JFBR" and "JFBRW", respectively, on August 26, 2022.
-$
MauiJoe
2 years ago
Press Release
Diamond Equity Research Releases Update Report on Medigus Ltd. (NASDAQ: MDGS)
MDGS
0.00%
Diamond Equity Research LLC
Thu, March 24, 2022, 7:00 AM
In this article:
MDGS
0.00%
NEW YORK, March 24, 2022 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released an update report on Medigus Ltd. (NASDAQ: MDGS). The update report includes detailed information on the Medigus’s business model, services, industry, valuation, management, and risks.
The full update report is available here. Highlights from the report include:
Strong Momentum in EV & Micro-Mobility Segment Targeting Growing Markets
Reverse Merger on OTC Markets - Medigus recently announced details of its planned spin-off and subsequent merger of its EV wireless charging business, Charging Robotics, Inc. The company signed a non-binding letter of intent for a planned securities exchange agreement with Fuel Doctor, Inc. (OTC: FDOC), a Delaware-based corporation. The transaction will result in Charging Robotics becoming a wholly owned subsidiary of Fuel Doctor, and in exchange, Medigus will receive 80% of the issued and outstanding share capital of Fuel Doctor. Through more available access to capital via the public equity markets, Charging Robotics is likely to enjoy greater flexibility in terms of financing alternatives, and greater liquidity. We view the transaction as a positive development and in line with the articulated business strategy of Medigus.
Meaningful Progress in EV & Micro-mobility Business - Medigus has displayed strong momentum in its EV & micro-mobility segment. In less than a year, Revoltz, an EV and wireless charging joint venture designed, manufactured, presented, and received its first order for its first model "Porto," for the last mile delivery market. This order is a part of a pilot project that is to be carried out at a new fully autonomous supermarket in Israel. While additionally, the recently acquired ParaZero Ltd. ("ParaZero"), a privately held company engaged in drone technology with an innovative patented safety system for drones, received a purchase order for its ParaZero SafeAirTM system from a leading global drone manufacturer.
Valuation - We have updated our financial model adjusting for the recent reverse merger and a minority stake in ParaZero Ltd. Our valuation approach yields a per-share value of $3.79 or $90.38 million contingent on successful execution by the company. The EV and micro-mobility business accounts for a majority, 52% of the company’s total value derived, while the online technologies and healthcare segment are at 28% and 20% respectively. Given the unique high-risk-reward opportunity, we view Medigus as a suitable investment for institutional and high-risk-tolerant retail investors.
Long_shortguy
2 years ago
Planned Spin-Off and Subsequent Merger of its EV Wireless
Medigus Announces Details of Planned Spin-Off and Subsequent Merger of its EV Wireless Charging Business
Friday, March 11, 2022 01:55:07 PM (GMT)
Charging Robotics signs LOI to complete reverse merger on OTC Markets
Tel Aviv, Israel, March 11, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, announced today that the Company and its wholly owned subsidiary, Charging Robotics Ltd., signed a non-binding letter of intent for a planned securities exchange agreement with Fuel Doctor, Inc. (OTC: FDOC), a Delaware corporation traded on the OTC Markets. The securities exchange agreement, if signed, will be subject to customary closing conditions.
The transaction will result in Charging Robotics becoming a wholly owned subsidiary of Fuel Doctor, and in exchange, Medigus will receive 80% of the issued and outstanding share capital of Fuel Doctor.
Upon closing, Medigus will appoint nominees as officers and directors of Fuel Doctor. As of the closing, FDOC shall have net cash in an amount of no less than $1.0 million, excluding Fuel Doctor’s expenses in connection with the contemplated transaction.
Charging Robotics is transforming the way electric vehicles are charged using its robotic platform to deliver automatic wireless charging. At the heart of the technology is a wireless power transfer module that uses resonance coils to transfer energy wirelessly from the robot to the vehicle.
The robotic platform is small enough to fit under vehicles, automatically positioning itself for maximum charging efficiency and returning to its docking station at the end of the charging operation. Once fully developed, Charging Robotics plans to install the system in public parking lots, providing a solution that dramatically lowers EV charging infrastructure installation costs relative to current alternatives.
About Charging Robotics
Charging Robotics is developing an automatic wireless charging system dedicated for public parking lots. The benefit of the robotic wireless charging system is that it will automatically align with high accuracy the energy transmitting device to the onboard energy receiving device thus allowing for very high charging efficiencies. The system will be fully automatic, thus eliminating the need for the driver to remove the car after charging is complete, which will increase the charger utilization and profits for the parking lot operator.
About Medigus
Based in Israel, Medigus Ltd. (Nasdaq: MDGS) is a technology company focused on innovative growth partnerships, mainly in advanced medical solutions, digital commerce and electric vehicle markets. Medigus' affiliations in the medical solutions arena include ownership in Polyrizon Ltd. and ownership in industry 4.0 company, ScoutCam Inc. The Company’s affiliates in digital commerce include Gix Internet Ltd., Jeffs' Brands Ltd. and Eventer Technologies Ltd. In the electric vehicle market, Charging Robotics Ltd. and Revoltz Ltd. are also part of the Company’s portfolio of technology solution providers. To learn more about Medigus’ advanced technologies, please visit http://www.medigus.com/.
Forward-Looking Statements
Long_shortguy
2 years ago
Investment they own:
The Company together with its subsidiaries held approximately USD 30 million in cash and cash equivalents as of June 30, 2021. No debt
ScoutCam Inc., Investment: SCTC Market cap $40M
On March 22, 2021, ScoutCam consummated a private placement of USD 20 million. Currently, the Company approximately owns 27.76% of the outstanding common stock of ScoutCam
Polyrizon
Following share purchase agreement Polyrizon signed with its current shareholders to raise an amount of USD 800 thousands, the Company invested an amount of USD 297 thousands on September 2, 2021. Currently the company hold 34.74% on Polyrizon on a fully diluted basis.
Smart Repair Pro Inc. and Purex Corp
On May 16, 2021, the Company entered into a stock exchange and plan of restructuring agreement, with Victor Hamon, an existing shareholder of Pro and Purex, on one hand and Jeffs’ Brands Ltd. (hereinafter - “Jeffs’ Brands”) on the other hand, pursuant to which, among other things, each of the Company and Vicky Hacmon transferred to Jeff’s Brands, all of Purex’s and Pro’ shares of common stock held by him (the “Transferred Shares”), in consideration of such number of Jeff’s Brands ordinary shares issued to the each of the Company and Victor Hacmon, in such number determined on the basis of the mechanics prescribed thereunder, thus resulting in each of Pro and Purex becoming a wholly-owned subsidiary of Jeff’s Brands. To date, the Company has invested approximately USD 5.4 million in Jeff’s Brands and holds 50.3% of its shares.
Eventer
Eventer consummated a share purchase agreement at an aggregate amount of USD 2.25 million, out of which the Company invested USD 300 thousand and currently holds approximately 47.69% of Eventer shares on a fully diluted basis. On June 3, 2021, Eventer submitted first public prospectus draft for the initial public offering (IPO) of Eventer’s shares on the Tel Aviv Stock Exchange Ltd.
100% of Charging Robotics Ltd ( Automax has option for 5% for 30M making value of $600M)
On June 17, 2021, Charging Robotics signed a definitive distribution agreement with Automax. As part of the Distribution Agreement, Automax will pay Charging Robotics a one-time payment of USD 50 thousand for its appointment as the exclusive distributor in Israel and Greece. Additionally, Automax will have a five year option to purchase up to 5% of Charging Robotics’ ordinary shares at a USD 30 million pre-money valuation on a fully diluted basis
Gix Internet Ltd.
Ad-Tech and Online Advertising - During 2020, the Company elected to convert all of its ordinary shares in Gix Media, into Gix Internet’s ordinary shares, as part of the Company’s investment agreement in Gix Internet. As of completion of the conversion rights the Company had, the Company owns approximately 33% of Gix Internet’s issued and outstanding share capital.
As of June 30, 2021, the Company also owns 5.1% of Elbit Imagining Ltd , 4.73% in Automax Ltd. (formerly known as Matomy Ltd.), 5., 2.09% in Maris-Tech Ltd. (hereinafter – “Maris”) and 0.8% in Safe Foods, Inc. (hereinafter – “SAFO”).
Revoltz Ltd
On February 19, 2021, the Company entered into a joint venture agreement, with Amir Zaid and Weijian Zhou and the Company’s wholly owned subsidiary, Charging Robotics, for the purpose of developing and commercializing three modular electric vehicle (EV) micro mobility vehicles for urban individual use and “last mile” cargo delivery. Pursuant to the terms of the joint venture agreement, the Company initially owns 19.99%, upon the consummation of an investment in a milestone financing of USD 1.350million in the aggregate, the Company will be entitled to own 50.01% of the issued and outstanding share capital of the joint venture.
https://medigus.com/wp-content/uploads/2021/08/Medigus_pres_Dec21_P-1_compressed.pdf
Long_shortguy
2 years ago
$MDGS, DRONEs Baby
Tel Aviv, Israel, Feb. 04, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, announced today that it has purchased approximately 40 percent of an Israeli drone technology company with an innovative patented safety system for drones.
This Israeli-drone company has developed a patented drone safety system which is designed to protect people and payloads, providing a solution to reduce the risk of a drone's possible malfunction in an urban environment. Unique in the industry, the system includes a smart parachute that monitors drone flight in real time, identifies critical failures, and autonomously triggers a parachute in the event of an emergency. This innovative solution aims to prevent the loss of drones that malfunction and crash, which potentially could save commercial drone operators millions in losses.
Chief Executive Officer of Medigus, Liron Carmel, commented: “We are thrilled to acquire a large percentage of this company. We believe its technology is a game changer in the industry. This is a very big win for Medigus.”
Long_shortguy
2 years ago
$MDGS: Jeffs Brands USA, IPO Sometime in 2022
Tel Aviv, Israel, Nov. 29, 2021 (GLOBE NEWSWIRE) — Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, announced that its 50.03% owned subsidiary, Jeffs’ Brands Ltd., a data-driven e-commerce company operating on the Amazon Marketplace, confidentially submitted a draft registration statement on Form F-1 to the U.S. Securities and Exchange Commission (the “SEC”) relating to a potential initial public offering of its ordinary shares in the United States. The timing, number of ordinary shares to be offered and the price range for the proposed offering have not yet been determined.
ProfitScout
2 years ago
$MDGS News: Medigus to Form New Joint Venture to Trade NFT Assets, Investing up to $5M
Medigus and Safee’s JV will engage in the purchase and sale of non-fungible tokens and other digital assets
Tel Aviv, Israel, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company developing advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, announced today that it has signed a non-binding memorandum of understanding (MOU) with Safee, a technology company focused on non-fungible tokens (NFTs). Per the agreement, the parties will embark on a joint venture to trade and monetize NFTs and other digital assets.
The JV will use Safee’s knowledge and platform to identify opportunities in the NFT field, and to buy, hold and monetize NFTs. Medigus will help fund the collaborative enterprise with a loan of up to $5 million for the purchase of NFTs and other digital assets. Medigus will also hold sway over management of the joint venture, appointing three of the four members of its board of directors, retaining hiring and firing rights of its CEO, and casting the decisive vote on budgetary and business planning matters.
In exchange for furnishing consulting services to the joint venture on the purchase and sale of NFTs and other digital assets, the non-binding MOU offers Safee an opportunity to buy Medigus stock. Over a period of three years, Safee may exercise the option to buy 200,000 shares of Medigus at the price of $10 per share.
Safee’s mission is to expand the reach of NFTs to mass market buyers and creators, digital artists, illustrators, photographers, musicians, regular consumer digital content creators and more. Safee’s social network allows creators and collectors to easily create, own, use, control and trade digital goods.
About Medigus
Based in Israel, Medigus Ltd. (Nasdaq: MDGS) is a technology company focused on innovative growth partnerships, mainly in advanced medical solutions, digital commerce and electric vehicle markets. Medigus’ affiliations in the medical solutions arena include ownership in ScoutCam Inc. and Polyzion Ltd. The Company’s affiliates in digital commerce include Gix Internet Ltd., Jeff’s Brands Ltd. and Eventer Technologies Ltd. In the electric vehicle market, Charging Robotics Ltd. and Revoltz are also part of the Company’s portfolio of technology solution providers. To learn more about Medigus’ advanced technologies, please visit http://www.medigus.com/.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. For example, Medigus uses forward-looking statements in this press release when it suggests the potential for the investment in Safee may or will lead to profitable growth in the future. Because such statements deal with future events and are based on Medigus’ current expectations, they are subject to various risks and uncertainties, and actual results, performance or achievements of Medigus could differ materially from those described in or implied by the statements in this press release.
The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed in any filings with the Securities and Exchange Commission (“SEC”). Except as otherwise required by law, Medigus undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Medigus is not responsible for the contents of third-party websites.
Company Contact:
Tali Dinar
Chief Financial Officer
+972-8-6466-880
ir@medigus.com
Investor Relations Contact:
Miri Segal
CEO
MS-IR LLC
+1-917-607-8654
msegal@ms-ir.com
Mr. Zen
2 years ago
Medigus to Form New Joint Venture to Trade NFT Assets, Investing up to $5M
Medigus and Safee's JV will engage in the purchase and sale of non-fungible tokens and other digital assets
Tel Aviv, Israel -- October 28, 2021 -- InvestorsHub NewsWire -- Medigus Ltd. (Nasdaq: MDGS), a technology company developing advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, announced today that it has signed a non-binding memorandum of understanding (MOU) with Safee, a technology company focused on non-fungible tokens (NFTs). Per the agreement, the parties will embark on a joint venture to trade and monetize NFTs and other digital assets.
The JV will use Safee's knowledge and platform to identify opportunities in the NFT field, and to buy, hold and monetize NFTs. Medigus will help fund the collaborative enterprise with a loan of up to $5 million for the purchase of NFTs and other digital assets. Medigus will also hold sway over management of the joint venture, appointing three of the four members of its board of directors, retaining hiring and firing rights of its CEO, and casting the decisive vote on budgetary and business planning matters.
In exchange for furnishing consulting services to the joint venture on the purchase and sale of NFTs and other digital assets, the non-binding MOU offers Safee an opportunity to buy Medigus stock. Over a period of three years, Safee may exercise the option to buy 200,000 shares of Medigus at the price of $10 per share.
Safee's mission is to expand the reach of NFTs to mass market buyers and creators, digital artists, illustrators, photographers, musicians, regular consumer digital content creators and more. Safee's social network allows creators and collectors to easily create, own, use, control and trade digital goods.
About Medigus
Based in Israel, Medigus Ltd. (Nasdaq: MDGS) is a technology company focused on innovative growth partnerships, mainly in advanced medical solutions, digital commerce and electric vehicle markets. Medigus' affiliations in the medical solutions arena include ownership in ScoutCam Inc. and Polyzion Ltd. The Company's affiliates in digital commerce include Gix Internet Ltd., Jeff's Brands Ltd. and Eventer Technologies Ltd. In the electric vehicle market, Charging Robotics Ltd. and Revoltz are also part of the Company's portfolio of technology solution providers. To learn more about Medigus' advanced technologies, please visit http://www.medigus.com/.
Mr. Zen
2 years ago
More News! Medigus: Polyrizon to Initiate Processes Towards FDA Submission
October 22 2021 - 07:35AM
GlobeNewswire Inc.
Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, announced today that Polyrizon Ltd., (37.01%), that it has engaged with a full-service Contract Research Organisation (CRO), to advise the Company in its pursuit of Food and Drug Administration (FDA) submission for its products.
The CRO provides high-value advisory services through its worldwide base of top-tier expert consultants to support product development life cycle, from initial concept to marketing authorization. Polyrizon and the CRO will start working on a readiness plan for Polyrizon’s preventative products for SARS-CoV-2, coronavirus, influenza and allergens, in order to prepare for U.S FDA submission.
Polyrizon, a clinical development biotech company, specializes in the development of innovative nasal gels to provide preventative treatment against a wide cross section of viruses, including COVID-19 and influenza, as well as bacteria, allergens, and other toxins. Polyrizon's proprietary Capture and ContainTM (“C&C”) hydrogel platform is delivered in the form of nasal sprays, and forms a thin gel-based protective shield containment barrier in the nasal cavity.
In recent pre-clinical studies, Polyrizon products demonstrated their potential in capturing and containing human coronavirus 229E and H1N1 influenza from interacting with epithelial host cells and by inhibiting cell death.
Polyrizon recently submitted a patent application for its products preventing of pathogens such as coronavirus and allergens from affecting nasal tissue.
About Medigus
Based in Israel, Medigus Ltd. (Nasdaq: MDGS) is a technology company focused on innovative growth partnerships, mainly in advanced medical solutions, digital commerce and electric vehicle markets. Medigus' affiliations in the medical solutions arena include ownership in ScoutCam Inc. and Polyzion Ltd. The Company’s affiliates in digital commerce include Gix Internet Ltd., Jeff's Brands Ltd. and Eventer Technologies Ltd. In the electric vehicle market, Charging Robotics Ltd. and Revoltz are also part of the Company’s portfolio of technology solution providers. To learn more about Medigus’ advanced technologies, please visit http://www.medigus.com/.
Mr. Zen
2 years ago
Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, announced today that its affiliate Eventer Technologies Ltd (47.69%), a smart ticketing platform enabling producers and venues to create virtual conferences and events, signed a memorandum of understanding (MOU) with Safee Cyber Technologies Ltd., a non-fungible token (NFT) technology company.
Eventer is a developer of advanced technology solutions for creating, marketing and managing events, including virtual events and conferences. By joining forces, Eventer will provide its customers, including original content creators and artists, with the ability to create and sell NFTs related to digital events, content and digital assets across Safee’s platform. Per the MOU, Eventer’s customers will have the opportunity to distribute their digital assets on a recurring revenue basis. Eventer and Safee will work in a revenue share model, based on Safee’s commission from NFT sales.
Safee’s social network allows creators and collectors to easily create, own, engage, control and trade digital goods. Safee’s mission is to expand the reach of NFTs to mass market buyers, creators, digital artists, illustrators, photographers, musicians, regular consumer digital content creators and more.
At a time when everyday users have become digital media producers, creators and artists, the intellectual property rights of digital creations (art, photos, videos, news, etc.) are rarely clear since the basic ownership model of the physical world does not translate to the virtual one. Connecting the two platforms will pave the way for creators to create content on Eventer’s smart platform and upload it to Safee’s NFT platform, allowing them to retain ownership and monetize their original creations. Moreover, as part of the MOU, each partner will share a stake in the other’s success. Upon the signing of a definitive agreement, Eventer will allocate to Safee ordinary shares of Eventer, and Safee will allocate to Eventer ordinary shares of Safee. The respective amounts will reflect Safee’s valuation of approximately. $35 million and Eventer’s valuation of approximately. $30 million.
Mr. Zen
3 years ago
Today's News. Medigus: Gix Completed Acquisition of Leading Media-Tech Company Cortex Group for Approximately $11 Million
October 14 2021 - 07:57AM
GlobeNewswire Inc.
Alert
Print
Share On Facebook
Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, announced today that its affiliate Gix Internet (38.01% on a fully diluted bases) (TASE: GIX), a global marketing technology (MarTech) solutions company for online performance-based-marketing, announced that Gix Internet’s subsidiary, Gix Media completed the acquisition of 70% of Cortex Group, an innovative media-tech company that has developed expertise in turning original content into a profit center through user traffic acquisition.
The acquisition was based on a Cortex pre-money valuation of approximately $15.6 million (NIS 50 million), out of which Gix Media’s 70% stake constituting approximately $ 11 million (NIS 35 million).
Cortex was established in 2017 and has since been operating with remarkable success in the field of online advertising. Cortex is an innovative media-tech company that has developed capabilities that enable the conversion of original content into a profit center by acquiring user traffic. Cortex’s business model is based on purchasing advertising space from publishers such as YAHOO, Outbrain, Verizon-Oath, Google and more. Cortex employs about 19 people in its offices in Tel Aviv.
Gix reported that according to Cortex’s financial statements for the first half of 2021, its revenues amounted to approximately $13.5 (NIS 43 million), an increase of 53% compared to its revenues in the first half of 2020, and Cortex’s operating profit for the first half of 2021 amounted to approximately $1.3 (NIS 4.2 million), an increase of 121% compared to the first half of 2020.
During the third quarter of 2021, Cortex continued to present an impressive growth, with revenues amounting to approximately $12.5 million (NIS 40 million), an increase of 92% compared with revenues in the corresponding quarter last year. Operating profit in the third quarter of 2021 amounted to approximately $1.4 million (NIS 4.5 million), an increase of 44% compared to the operating profit of the third quarter of 2020.
Cortex’s financial results will be consolidated with Gix’s financial statements, as of the acquisition date and are expected to contribute significantly to Gix’s consolidated results for 2021.
Hunter120
3 years ago
$MDGS released some awesome news today about investing nearly half a million dollars into a NFT business but investors need to know they have many business ventures and are bringing in some very significant revenues rig now. This is a solid company. When you look back through their filings and PR’s, you’ll see things such as the Medigus board of directors authorized the Company to take action to promote a $2 million share buyback program, they signed a non-binding LOI to acquire the controlling interest in a B2B/B2C electronics wholesale distributor, they commenced manufacturing of Revoltz’s ModelOne prototype, polyrizon submits additional patent application for prevention of pathogens such as coronavirus and allergens from affecting nasal tissue, gix Internet acquires 70% stake in Cortex Group for $11 million…. There’s some amazing stuff here and it’s clear those huge revenues will continue to expand. Do yourself a favour and look into this one yourself … I did today and love what I see
Moose Cat
3 years ago
Big news today with the NFT’s but looking at the previous news releases, you really get a god snap shot of how solid this company is. Their revenues are absolutely amazing here. Revenues for the six-month period ended June 30, 2021, reached a record high, and totaled $2,393,000, an increase of $2,320,000 compared to $73,000 in the six-month period ended June 30, 2020. Net income for the period reached a record of $7,927,000 compared to a net loss of $3,599,000 in the six-month period ended June 30, 2021. Solid, solid investment.
Ryguy008
3 years ago
Great to see them getting a head start on NFT's. That's a big investment too...
Financials from yesterday's release...
"Medigus recently announced record financial results for the six months ended June 30, 2021. Revenues reached a record high, and totaled $2,393,000. Net income for the period reached a record of $7,927,000. Shareholders’ equity totaled $53,904,000 in cash, and cash equivalents totaled $29,642,000 as of June 30, 2021"
https://finance.yahoo.com/news/medigus-announces-corporate-rebranding-launch-131500370.html
$MDGS
Moose Cat
3 years ago
$MDGS just dropped news this morning that they entered the Non-Fungible Token (NFT) market with an investment of nearly half a million dollars in the Safee company! The NFT sector is extremely popular right now and Safee’s social network allows creators and collectors to easily create, own, engage, control and trade digital goods. Safee’s mission is to expand the reach of NFTs to mass market buyers and creators, digital artists, illustrators, photographers, musicians, regular consumer digital content creators and more. Check out their website at www.Safee.io. $MDGS stock should do extremely good in the coming weeks.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Gentlemen Prefer Bonds
11 months ago
jedijazz
2 years ago
i_like_bb_stock
3 years ago
Golden Cross
3 years ago
Hot Features
Premium
